Results 151 to 160 of about 41,447 (182)
Some of the next articles are maybe not open access.
Chronic myelogenous leukemia of childhood
The Indian Journal of Pediatrics, 1987Chronic myelogenous leukemia is relatively uncommon in childhood, occurring as both an “adult” and “juvenile” form. The clinical presentation and course are fairly well defined, especially for the adult type. Though extensive advances in understanding the pathogenesis and cytogenetics of the adult form have been made in the last 25 years, treatment is ...
openaire +2 more sources
Hypofibrinogenemia in Chronic Myelogenous Leukemia
JAMA: The Journal of the American Medical Association, 1979To the Editor.— Favis and his colleagues (240:1953, 1978) state that as a complication of chronic myelogenous leukemia hypofibrinogenemic bleeding "has been reported only once previously." They overlooked three other case reports.1-3One1of these three patients also had chloromas containing sea-blue histiocytes, and in the other two patients,2,3blastic
openaire +2 more sources
Journal of the American Medical Association, 1924
Irradiation treatment of chronic myelogenous leukemia was first undertaken by Senn 1 in 1903, using long wave length roentgen rays. It was not until after Renon, Degrais and Desbouis, 2 in 1913, and Ordway, 3 in 1917, reported the effect of radium on the disease that adequate irradiation was given at all frequently so as to produce very often marked ...
GEORGE R. MINOT +2 more
openaire +1 more source
Irradiation treatment of chronic myelogenous leukemia was first undertaken by Senn 1 in 1903, using long wave length roentgen rays. It was not until after Renon, Degrais and Desbouis, 2 in 1913, and Ordway, 3 in 1917, reported the effect of radium on the disease that adequate irradiation was given at all frequently so as to produce very often marked ...
GEORGE R. MINOT +2 more
openaire +1 more source
JAMA, 1983
A 50-year-old man had chronic myelogenous leukemia and entered a blast crisis that was both morphologically and histochemically lymphoid. The blasts contained terminal deoxyribonucleotidyl transferase and expressed lymphoblastic leukemia-associated antigen. He rapidly entered remission with vincristine sulfate and prednisone therapy.
openaire +1 more source
A 50-year-old man had chronic myelogenous leukemia and entered a blast crisis that was both morphologically and histochemically lymphoid. The blasts contained terminal deoxyribonucleotidyl transferase and expressed lymphoblastic leukemia-associated antigen. He rapidly entered remission with vincristine sulfate and prednisone therapy.
openaire +1 more source
Journal of the American Medical Association, 1931
Any discussion of the value of irradiation in myelogenous leukemia must be based on a knowledge of the natural course of this disease. The duration of life in untreated cases is not well known; statistics are few, and the following factors make difficult the determination of this point: The disease is comparatively rare, and the literature contains ...
openaire +1 more source
Any discussion of the value of irradiation in myelogenous leukemia must be based on a knowledge of the natural course of this disease. The duration of life in untreated cases is not well known; statistics are few, and the following factors make difficult the determination of this point: The disease is comparatively rare, and the literature contains ...
openaire +1 more source
Chronic Myelogenous Leukemia — New Concepts
New England Journal of Medicine, 1981H Phillip Koeffler +2 more
exaly +2 more sources
Therapy of chronic myelogenous leukemia
Stem Cells, 1993H M, Kantarjian, M, Talpaz
openaire +2 more sources
Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in China
Leukemia and Lymphoma, 2002Zhijian Xiao, Bingcheng Liu
exaly
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
New England Journal of Medicine, 2002Hagop Kantarjian +2 more
exaly